Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-31.15%
0%
-31.15%
6 Months
-46.75%
0%
-46.75%
1 Year
-60.61%
0%
-60.61%
2 Years
-83.13%
0%
-83.13%
3 Years
-84.61%
0%
-84.61%
4 Years
-90.42%
0%
-90.42%
5 Years
-94.72%
0%
-94.72%
Mauna Kea Technologies SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.00%
EBIT Growth (5y)
9.69%
EBIT to Interest (avg)
-9.64
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.19
Sales to Capital Employed (avg)
0.94
Tax Ratio
7.95%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.20
EV to EBIT
-6.44
EV to EBITDA
-8.57
EV to Capital Employed
16.09
EV to Sales
5.04
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-249.87%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
7.70
10.50
-26.67%
Operating Profit (PBDIT) excl Other Income
-5.00
-4.50
-11.11%
Interest
0.70
0.30
133.33%
Exceptional Items
0.00
-0.00
Consolidate Net Profit
-10.40
-3.70
-181.08%
Operating Profit Margin (Excl OI)
-889.50%
-594.80%
-29.47%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -26.67% vs 40.00% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -181.08% vs 66.96% in Dec 2023
About Mauna Kea Technologies SA 
Mauna Kea Technologies SA
Pharmaceuticals & Biotechnology
Mauna Kea Technologies SAS, also known as Mauna Kea Technologies SA, is a France-based company active in the healthcare business sector. It specializes in designing, developing, and selling medical imaging tools and systems. The Company’s products, used mainly in endoscopy, are intended for viewing and detecting deficiencies in the gastrointestinal and respiratory systems, primarily focusing on patients suffering from cancer. The main product offered by the Company is Cellvizio, a probe-based Confocal Laser Endomicroscopy (pCLE) which is a system providing physicians and researchers with high resolution cellular images of tissue in a real-time structure. The Company has marketing authorizations in Thailand, the United Kingdom, the USA, Brazil, Chile, South Korea, Poland, Russia and Saudi Arabia, among others.
Company Coordinates 
Company Details
9, rue d'Enghien , PARIS None : 75010
Registrar Details






